CLINICAL_TRIALS
trial_result
· 2024-11-01
Clinical Trial Update: Revefenacin in Chinese Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease(COPD) [Phase 3]
Summary
Phase 3 trial of revefenacin in Chinese adults with moderate to very severe chronic obstructive pulmonary disease has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mylan Pharma UK Ltd. | Conditions: COPD | Phase 3 | Status: COMPLETED | Results posted: 2024-11-01